3 assets in Glucose Intolerance

Therapeutic assets addressing Glucose Intolerance, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dulaglutide Glucose Intolerance	University of Pennsylvania	P4	BBB (75)
Vigabatrin Glucose Intolerance	University of Arizona	P2	CCC (53)
Oxygen Glucose Intolerance	Johns Hopkins University	N/A	D (30)